Ocules SRL
2.0 FTEThe score of Ocules shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +59 % Total assets -35 % Headcount (avg FTE) +43 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ocules's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −8,551 € | ||||
| Equity | 78,033 € | ||||
| Cash | 18,280 € | ||||
| EBITDA | 110,931 € | ||||
| Total assets | 532,581 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jun 2026
- Year ended 31 Dec 2024filed on 30 Jul 2025
- Year ended 31 Dec 2023filed on 30 Jul 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
- Year ended 31 Dec 2021filed on 29 Jul 2022
Ocules's financial analysis
- Solvency14.7%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ocules
Ocules's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0772.666.960
- VAT number
- BE0772666960
- Peppol
- Registered · 0208:0772666960 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Aug 2021
- Registered office
- 3460 Bekkevoort
- Size
- Micro · 2.0 FTE
- Latest accounts
- 2025 · filed on 22 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
Ocules (SRL) has been based in Bekkevoort since 2021, active in: medical specialists activities. For 2025, it reports a net loss of 8,551 € and equity of 78,033 €; its revenue is not published. With 2.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 14.7%, below the median of its sector (72.2%).
Companies similar to Ocules
Companies in the same business, of comparable size and area, outside its group.
- Dr. Valerie Bourmanne, anesthesiste Office administrative and support activities Glabbeek · balance sheet 465,769 €
- Cabinet D'Orthopedie Lefebvre Bernard Medical specialists activities Lasne · balance sheet 521,314 €
- DR. BERNARD PEENE, Endocrinologie Medical specialists activities Herselt · balance sheet 510,276 €
- Dr. Colle Isabelle, gastro-enteroloog Medical specialists activities Wetteren · balance sheet 635,632 €
- Dokter Christel Linsen Medical specialists activities Lommel · balance sheet 426,228 €
- Dr. Eno Lavrysen Neurochirurgie Medical specialists activities Mortsel · balance sheet 413,674 €
- DR. Isabelle Libert, MKA-Chirurgie Medical specialists activities Zwalm · balance sheet 737,833 €
- Hagyas Medical specialists activities Hasselt · balance sheet €1.13m
Frequently asked questions about Ocules
What is the revenue of Ocules?
Ocules files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Ocules?
In Belgium, the VAT number is the company number prefixed with BE: BE0772666960 for Ocules, if the company is VAT-registered. Its company number (CBE) is 0772.666.960.
Where is the registered office of Ocules?
According to the CBE register, the registered office of Ocules is in 3460 Bekkevoort.
What is the equity of Ocules?
At the close of the 2025 financial year, the equity of Ocules amounts to 78,033 €, a solvency of 14.7% of total assets.
How many people work at Ocules?
2.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Ocules?
The register lists 4 active mandates at Ocules. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ocules
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →